New nanoparticle-based AFlavs improve high-resolution imaging while enabling ischemia-reperfusion analysis, suggesting enhanced bioimaging options.
The development of small-molecule near-infrared-II (NIR-II) fluorophores for high-contrast bioimaging is desirable, but challenging. Here, we report the design of a new class of NIR-II dyes, named AFlavs, created via framework integration of flavylium and polymethine scaffolds. These asymmetric molecules exhibit high brightness (227-2396 M⁻¹ cm⁻¹), superior photostability, and strong resistance to quenching, making them ideal for advanced bioimaging. Among them, AFlav-4 stands out for its performance in vascular imaging, including tumor vasculature disruption, ischemia-reperfusion evaluation, and bone-targeted delivery via nanoparticles. Notably, AFlavs enabled two-, three-, and four-color multiplex imaging via more than 100 nm absorption separation, achieving spectral orthogonality uncommon among the currently reported small-molecule NIR-II fluorophores. These findings demonstrate the potential of AFlavs for high-resolution, multicolor, and long-term NIR-II imaging in vivo.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: